Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
roflumilast (daliresp) (1 trial)
Lung Diseases, Obstructive (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Trials (1 total)
Trial APIs (1 total)